within Pharmacolibrary.Drugs.ATC.R;

model R03CA02_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.38333333333333336,
    adminDuration  = 600,
    adminMass      = 0.025,
    adminCount     = 1,
    Vd             = 0.00191,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Ephedrine is a sympathomimetic amine used as a medication and stimulant. It is primarily employed to prevent low blood pressure during anesthesia, for the treatment of nasal congestion, and historically as a bronchodilator for asthma. Due to potential side effects and abuse, its use for asthma and as an over-the-counter stimulant has become less common; however, it remains approved and is still used in clinical settings worldwide for specific indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from healthy adult subjects after intravenous administration.</p><h4>References</h4><ol><li><p>Dingemanse, J (1993). An update of recent moclobemide interaction data. <i>International clinical psychopharmacology</i> 7(3-4) 167–180. DOI:<a href=&quot;https://doi.org/10.1097/00004850-199300730-00008&quot;>10.1097/00004850-199300730-00008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8468439/&quot;>https://pubmed.ncbi.nlm.nih.gov/8468439</a></p></li><li><p>Till, AE, &amp; Benet, LZ (1979). Pseudoephedrine pharmacokinetics in the rat using a microanalysis technique. <i>Pharmacology</i> 18(6) 306–310. DOI:<a href=&quot;https://doi.org/10.1159/000137270&quot;>10.1159/000137270</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/493335/&quot;>https://pubmed.ncbi.nlm.nih.gov/493335</a></p></li><li><p>Cooper, DW, et al., &amp; Koneti, KK (2007). Effect of intravenous vasopressor on spread of spinal anaesthesia and fetal acid-base equilibrium. <i>British journal of anaesthesia</i> 98(5) 649–656. DOI:<a href=&quot;https://doi.org/10.1093/bja/aem056&quot;>10.1093/bja/aem056</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17347185/&quot;>https://pubmed.ncbi.nlm.nih.gov/17347185</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R03CA02_1;
